Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate

Go back to Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate
Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.41 --0 (-0%)
Previous Close $10.41    52 Week High $9.23 
Open $10.41    52 Week Low $1.16 
Day High $10.41    P/E N/A 
Day Low $10.41    EPS $-0.30 
Volume 5,704       

Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.41 --0 (-0%)
Previous Close $10.41    52 Week High $9.23 
Open $10.41    52 Week Low $1.16 
Day High $10.41    P/E N/A 
Day Low $10.41    EPS $-0.30 
Volume 5,704